Gujarat Inject (Kerala) Ltd Financial Ratios
GUJINJECLTD · Healthcare · Current price
P/E ratio
60.8x
P/B ratio
15.1x
ROE
16.6%
ROCE
13.5%
Debt / Equity
0.00
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 60.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 15.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 13.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Gujarat Inject (Kerala) Ltd's latest numbers.
Gujarat Inject (Kerala) Ltd profitability
Gujarat Inject (Kerala) Ltd generates a return on equity of 16.6% and a return on capital employed of 13.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 60.8x, Gujarat Inject (Kerala) Ltd is conservatively financed. Our overall business-quality score for the company is 3.3 / 10.
Understand the ratios
More on Gujarat Inject (Kerala) Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.